538 related articles for article (PubMed ID: 18268283)
21. Rho GTPases and regulation of hematopoietic stem cell localization.
Williams DA; Zheng Y; Cancelas JA
Methods Enzymol; 2008; 439():365-93. PubMed ID: 18374178
[TBL] [Abstract][Full Text] [Related]
22. Histone deacetylase inhibitors trichostatin A and valproic acid circumvent apoptosis in human leukemic cells expressing the RUNX1 chimera.
Sasaki K; Yamagata T; Mitani K
Cancer Sci; 2008 Feb; 99(2):414-22. PubMed ID: 18271940
[TBL] [Abstract][Full Text] [Related]
23. Modulation of adhesion and growth of colon and pancreatic cancer cells by the histone deacetylase inhibitor valproic acid.
Jones J; Bentas W; Blaheta RA; Makarevic J; Hudak L; Wedel S; Probst M; Jonas D; Juengel E
Int J Mol Med; 2008 Sep; 22(3):293-9. PubMed ID: 18698487
[TBL] [Abstract][Full Text] [Related]
24. Effect of histone deacetylase inhibitor valproic acid on progenitor cells of acute myeloid leukemia.
Bug G; Schwarz K; Schoch C; Kampfmann M; Henschler R; Hoelzer D; Ottmann OG; Ruthardt M
Haematologica; 2007 Apr; 92(4):542-5. PubMed ID: 17488665
[TBL] [Abstract][Full Text] [Related]
25. Migration of acute lymphoblastic leukemia cells into human bone marrow stroma.
Makrynikola V; Bianchi A; Bradstock K; Gottlieb D; Hewson J
Leukemia; 1994 Oct; 8(10):1734-43. PubMed ID: 7523799
[TBL] [Abstract][Full Text] [Related]
26. Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia.
Matsunaga T; Fukai F; Miura S; Nakane Y; Owaki T; Kodama H; Tanaka M; Nagaya T; Takimoto R; Takayama T; Niitsu Y
Leukemia; 2008 Feb; 22(2):353-60. PubMed ID: 17972943
[TBL] [Abstract][Full Text] [Related]
27. Carboxypeptidase M expressed by human bone marrow cells cleaves the C-terminal lysine of stromal cell-derived factor-1alpha: another player in hematopoietic stem/progenitor cell mobilization?
Marquez-Curtis L; Jalili A; Deiteren K; Shirvaikar N; Lambeir AM; Janowska-Wieczorek A
Stem Cells; 2008 May; 26(5):1211-20. PubMed ID: 18292211
[TBL] [Abstract][Full Text] [Related]
28. Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways.
Scupoli MT; Donadelli M; Cioffi F; Rossi M; Perbellini O; Malpeli G; Corbioli S; Vinante F; Krampera M; Palmieri M; Scarpa A; Ariola C; Foà R; Pizzolo G
Haematologica; 2008 Apr; 93(4):524-32. PubMed ID: 18322253
[TBL] [Abstract][Full Text] [Related]
29. The role of platelet/endothelial cell adhesion molecule 1 (CD31) and CD38 antigens in marrow microenvironmental retention of acute myelogenous leukemia cells.
Gallay N; Anani L; Lopez A; Colombat P; Binet C; Domenech J; Weksler BB; Malavasi F; Herault O
Cancer Res; 2007 Sep; 67(18):8624-32. PubMed ID: 17875702
[TBL] [Abstract][Full Text] [Related]
30. Platelet factor 4 enhances the adhesion of normal and leukemic hematopoietic stem/progenitor cells to endothelial cells.
Zhang J; Lu SH; Liu YJ; Feng Y; Han ZC
Leuk Res; 2004 Jun; 28(6):631-8. PubMed ID: 15120941
[TBL] [Abstract][Full Text] [Related]
31. Detection of minimal residual disease in acute myelogenous leukemia by RNA-in situ hybridization.
Evinger-Hodges MJ; Spinolo JA; Spencer V; Nieto P; Dicke KA
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():13-5. PubMed ID: 2653488
[TBL] [Abstract][Full Text] [Related]
32. Expression of beta 1 integrin mRNAs in human leukemic blasts.
Janiak M; Sawicki G; Janowska-Wieczorek A
Leukemia; 1994 Sep; 8(9):1544-50. PubMed ID: 7522292
[TBL] [Abstract][Full Text] [Related]
33. Purification of an in vitro inhibitor of normal myelopoiesis using a monoclonal antibody directed to a common antigen of myelogenous leukemia (CAMAL).
Shellard JE; Leitch HA; Logan PM; McMaster WR; Levy JG
Exp Hematol; 1991 Feb; 19(2):136-42. PubMed ID: 1991495
[TBL] [Abstract][Full Text] [Related]
34. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
Zeleznikova T; Stevulova L; Kovarikova A; Babusikova O
Neoplasma; 2007; 54(6):471-7. PubMed ID: 17949229
[TBL] [Abstract][Full Text] [Related]
35. Effects of human monoclonal antibody 216 on B-progenitor acute lymphoblastic leukemia in vitro.
Bieber MM; Twist CJ; Bhat NM; Teng NN
Pediatr Blood Cancer; 2007 Apr; 48(4):380-6. PubMed ID: 16421902
[TBL] [Abstract][Full Text] [Related]
36. The CysLT1 ligand leukotriene D4 supports alpha4beta1- and alpha5beta1-mediated adhesion and proliferation of CD34+ hematopoietic progenitor cells.
Boehmler AM; Drost A; Jaggy L; Seitz G; Wiesner T; Denzlinger C; Kanz L; Möhle R
J Immunol; 2009 Jun; 182(11):6789-98. PubMed ID: 19454674
[TBL] [Abstract][Full Text] [Related]
37. Expression of VLA molecules on acute leukemia cells: relationship with disease characteristics.
Vila L; Thomas X; Campos L; Sabido O; Archimbaud E
Exp Hematol; 1995 Jun; 23(6):514-8. PubMed ID: 7768307
[TBL] [Abstract][Full Text] [Related]
38. [Role of peptide regulatory factors in the proliferation of leukemic blasts].
Tabilio A; Falzetti F; Mannoni P; Martelli MF
Haematologica; 1991 Jun; 76 Suppl 3():85-92. PubMed ID: 1752546
[No Abstract] [Full Text] [Related]
39. Membrane protein hMYADM preferentially expressed in myeloid cells is up-regulated during differentiation of stem cells and myeloid leukemia cells.
Wang Q; Li N; Wang X; Shen J; Hong X; Yu H; Zhang Y; Wan T; Zhang L; Wang J; Cao X
Life Sci; 2007 Jan; 80(5):420-9. PubMed ID: 17097684
[TBL] [Abstract][Full Text] [Related]
40. Correlation between VLA-4 integrin and hematopoietic cell migration.
Chen T; Xie Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):230-4. PubMed ID: 12844401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
